Testosterone Supplementation in Men with MCI.
Phase of Trial: Phase III
Latest Information Update: 16 Sep 2014
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism; Mild cognitive impairment
- Focus Biomarker; Therapeutic Use
- Acronyms HIP
- 31 Aug 2018 Biomarkers information updated
- 18 Jun 2012 Actual patient number 23 added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Actual end date (1 May 2012) added as reported by ClinicalTrials.gov.